Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
The candidate will develop and benchmark zero-shot multimodal fusion models for rare disease prediction, using melanoma as a use case. The project integrates spatial and single-cell multi-omics data with
-
and cost-effective AAV-based gene therapy. A key barrier in resolving this bottleneck is the limited understanding of AAV biology. For example, how host cells, helper viruses, and AAV gene products
-
advancing the next generation of spatial single-cell omics technologies for precision medicine. Bringing together leading European universities, technology providers, clinical partners and innovative
-
independently while thriving in a collaborative multidisciplinary team- Is fluent in English Experience with cell culture, molecular biology, mass spectrometry, bioinformatics, programming or omics technologies
-
this hypothesis. Specific tasks for the PhD position are:Building on data obtained during previous PhD projects on the topic, you will use various molecular cell biological, biochemical, gene transfer
-
. You will extract and interpret fully detailed phenotypic fingerprints at whole-well and single‑cell resolution in virus-infected cell cultures. AI models will be used to cluster compounds and infer
-
. Experience with cell culture and/or animal experimentation. FELASA B certification or eligibility to obtain certification. Strong scientific writing and communication skills. A PhD position in a cutting-edge
-
is available at the Department of Oncology, Laboratory of Lipid Metabolism and Cancer, within the KU Leuven Institute for Single Cell Omics, at KU Leuven. The project has a duration of 36-months. PhD
-
17 Sep 2026 Job Information Organisation/Company KU LEUVEN Research Field Physics » Solid state physics Physics » Quantum mechanics Physics » Applied physics Researcher Profile First Stage
-
will Lead viral vector design, development, and production activities within LMVGT Develop of producer cell lines, optimize production, and scale up manufacturing processes for viral vectors and VLPs